Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M998Revenue $M47.8Net Margin (%)-139.1Z-Score-3.6
Enterprise Value $M963EPS $-1.3Operating Margin %-116.6F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-138.8Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio1.3Cash flow > EarningsY
Price/Sales12.85-y EBITDA Growth Rate %-36.3Current Ratio1.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-59.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M106ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with MACK

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

MACK is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


MACK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stewart Edward J.SVP & Pres, Healthcare Sol 2015-01-15Sell6,000$11.19-14.03view
Sullivan William A.CFO and Treasurer 2014-12-24Sell15,000$10.7-10.09view
Lee Vivian SDirector 2014-12-23Buy20,000$10.23-5.96view
Sinskey Anthony JDirector 2014-12-18Sell20,000$10.31-6.69view
Stewart Edward J.SVP & Pres, Healthcare Sol 2014-12-15Sell6,000$10.63-9.5view
Mulroy Robert J.President and CEO 2014-12-08Sell200,000$9.84-2.24view
Stewart Edward J.SVP & Pres, Healthcare Sol 2014-12-05Sell3,000$10-3.8view
PORTER MICHAEL EDirector 2014-12-02Buy8,000$8.7110.45view
PORTER MICHAEL EDirector 2014-11-21Buy11,909$8.878.46view
Stewart Edward J.SVP & Pres, Healthcare Sol 2014-11-18Sell5,000$8.5512.51view

Press Releases about MACK :

    Quarterly/Annual Reports about MACK:

    News about MACK:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Starbucks Corp, KD Supply Holdings Inc, Capital One Financial Corp, Merr Dec 14 2014 

    More From Other Websites
    MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 22 2015
    Merrimack Pharmaceuticals Names Birgit M. Schoeberl, Ph.D. as Head of Discovery Division and... Jan 22 2015
    Merrimack Pharmaceuticals Names Birgit M. Schoeberl, Ph.D. as Head of Discovery Division and... Jan 22 2015
    Merrimack Reveals Additional Data from Oncology Candidate - Analyst Blog Jan 22 2015
    Merrimack Pharmaceuticals Presents Additional Analyses of Phase 3 MM-398 NAPOLI-1 Study at the... Jan 20 2015
    Merrimack Pharmaceuticals Presents Additional Analyses of Phase 3 MM-398 NAPOLI-1 Study at the... Jan 20 2015
    Merrimack Pharmaceuticals Announces Oral Presentation of Additional Analyses of MM-398 Phase 3... Jan 08 2015
    Merrimack Pharmaceuticals Announces Oral Presentation of Additional Analyses of MM-398 Phase 3... Jan 08 2015
    Merrimack Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 07 2015
    Merrimack Pharmaceuticals Announces the Addition of Russell T. Ray to Its Board of Directors Dec 17 2014
    MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Dec 17 2014
    Merrimack Pharmaceuticals Announces the Addition of Russell T. Ray to Its Board of Directors Dec 17 2014
    Merrimack Pharmaceuticals Presents Research on Innovative Pipeline for Patients With Breast Cancer... Dec 12 2014
    Merrimack Pharmaceuticals Presents Research on Innovative Pipeline for Patients With Breast Cancer... Dec 12 2014
    Video Release -- Preclinical Research Differentiating the Activity of Merrimack's MM-398,... Dec 04 2014
    Video Release -- Preclinical Research Differentiating the Activity of Merrimack's MM-398,... Dec 04 2014
    Merrimack Pharmaceuticals to Present at Oppenheimer 25th Annual Healthcare Conference, Hold Analyst... Dec 01 2014
    Merrimack Pharmaceuticals to Present at Oppenheimer 25th Annual Healthcare Conference, Hold Analyst... Dec 01 2014
    Insider Trading Alert - FCS, GDOT And MACK Traded By Insiders Nov 25 2014
    Merrimack Pharmaceuticals Presents on Multiple Programs at the 26th EORTC-NCI-AACR Symposium on... Nov 21 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK